DSpace About DSpace Software 日本語

01 奈良県立医科大学 >
011 医学部 >
0112 紀要 >
01121 Journal of Nara Medical Association >
Vol.73 No.1,2,3 >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10564/4185

Title: Efficacy Of A Combination Of Transarterial Chemoembolization And Radiation Therapty For Patients With Hepatochellular Carcinoma Ineligible For Resection Or Radiofrequency Ablation.
Authors: Inoue, Masayoshi
Takahama, Junko
Kunichika, Hideki
Shimoda, Emiko
Morimoto, Kengo
Nikimoto, Mei
Inooka, Nobuyoshi
Hasegawa, Masatoshi
Keywords: hepatocellular carcinoma
radiation therapy
stereotactic body radiotherapy
transarterial chemoembolization
radiofrequency ablation
treatment outcome
Issue Date: 30-Jun-2022
Publisher: 奈良医学会
Citation: Journal of Nara Medical Association Vol.73 No.1,2,3 p.1-9 (2022.06)
Abstract: Purpose: The local control rate of trans-arterial chemoembolization (TACE) for the patients with hepatocellular carcinoma (HCC) was unsatisfactory compared to resection or radiofrequency ablation (RFA). To increase the local control rate for tumors, we performed radiation therapy followed by TACE in our institution. The purpose of this study was to evaluate the efficacy and toxicity of the TACE and radiotherapy combination in HCC patients ineligible for resection or RFA. Material and Methods: Between January 2017 and April 2020, 33 patients with HCC ineligible for resection or RFA were treated with a combination of TACE and radiation therapy. Eight patients were initial cases, and 25 were recurrent or residual cases. A total dose of 40-60 Gy in 5-20 fractions was delivered to the 50-90% isodose line. Results: The median follow-up period was 16 months (range, 6-47 months); the objective response rate was 66.7%; and the 1- and 2-year overall survival rates, 72.7% and 62.5%, respectively. The objective response rate for HCCs <5 em was 79.2%; the 1- and 2-year overall survival rates, 91.7% and 62.5%, respectively; median progression-free survival, 13.5 months (range, 3-47 months), and the 1- and 2-year local progression-free survival rates, 95.8% and 85.7%, respectively. There was one case each of grade 2 radiation esophagitis and ascites after three months of irradiation. Conclusion: The combination of TACE and radiation therapy shows good local control and acceptable toxicity, particularly in HCCs <5 cm and may be a good treatment option.
URI: http://hdl.handle.net/10564/4185
ISSN: 13450069
Appears in Collections:Vol.73 No.1,2,3

Files in This Item:

File Description SizeFormat
1-9p..pdf7.07 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback